Repurposing drugs to eliminate cellular origins of brain tumors

Glioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy including surgery, irradiation, and chemotherapy. It has become clear in recent years that not all cells within the brain tumor have an equal potential to divide and drive tumor growth.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup